LMND Stock Soars After Q3 Beat and Guidance Raise: Revenue +42%, Loss Ratio at Record Low (Nov. 5, 2025)

5 November 2025

Lemonade (NYSE: LMND) ripped higher on Wednesday after posting stronger‑than‑expected Q3 2025 results and lifting its full‑year outlook, with investors cheering evidence of faster growth and improving underwriting quality.

What happened

Lemonade reported Q3 revenue of $194.5 million (+42% YoY), an adjusted loss of $0.51 per share (narrowed from $0.95 a year ago), and raised 2025 revenue guidance to $727–$732 million (from $710–$715 million). Shares spiked on the news as results topped consensus and the outlook improved. ^[1]

The numbers that moved the stock

In‑Force Premium (IFP):$1.16 billion, up 30% YoY, marking an eighth straight quarter of accelerating growth. ^[2]
Customers:2.87 million, up 24% YoY; premium per customer rose 5% to $403. ^[3]
Gross profit:$80 million, up 113% YoY; gross profit margin expanded to 41%. ^[4]
Underwriting quality:Gross loss ratio fell to 62% (record low); trailing‑12‑month loss ratio improved to 67%. ^[5]
Profit path:Adjusted EBITDA loss improved to ($26) million; net loss narrowed to about ($38) million; adjusted free cash flow was +$18 million and cash from operations was +$5 million. ^[6]

Guidance and outlook

Management raised full‑year 2025 targets across IFP, GEP, revenue, and adjusted EBITDA and now expects Q4 revenue of $217–$222 million. Lemonade reiterated its plan to achieve positive adjusted EBITDA for a full quarter by Q4 2026. ^[7]

Why investors care

Two pillars are driving the rerating:

Operating leverage from AI & automation. Lemonade says AI‑driven automation has pushed its loss adjustment expense (LAE) ratio down to ~7% from ~13% over three years, indicating much leaner claims handling as the company scales. ^[8]
Improving auto insurance (Car) economics.Car gross loss ratio improved to ~76% and IFP in the segment reached ~$163 million (~40% YoY), with more state launches ahead (Pennsylvania “in the coming months”). ^[9]

Street/market reaction on Nov. 5

Media and analyst coverage highlighted the beat and guidance raise, with several outlets attributing the jump to faster growth and sharply better loss ratios. ^[10]
Technical momentum: LMND set a new 52‑week high intraday as the stock vaulted on earnings; some coverage flagged the move above key buy points. Year‑to‑date performance is now up well over 100%. ^[11]

Key quote (paraphrased from shareholder letter)

Management emphasized that, two years ago, Lemonade was growing more slowly with lower margins; today, growth is faster, margins are higher, and net loss as a percentage of premium has improved markedly, outlining a clear path to profitability as operating costs stay relatively stable excluding growth spend. ^[12]

Risks and what to watch next

Retention: Annual Dollar Retention dipped to 85% (down ~2 points YoY) due to pruning policies that didn’t meet underwriting criteria. Watch whether retention stabilizes as pricing and selection models mature. ^[13]
Execution on guidance: The bar is higher after today’s pop—investors will look for continued loss‑ratio gains, topline growth near 30%, and positive adjusted EBITDA on the timeline management outlined. ^[14]
Auto rollout: Additional state launches (including Pennsylvania) and cross‑sell to Lemonade’s existing base are catalysts; unit economics in Car remain a swing factor. ^[15]

LMND stock today (Nov. 5 snapshot)

Price: ~$78
Day change: +~33%
Day range: ~$56.9 – ~$79.7
Volume: ~11.2M (intraday)
Market cap: ~$3.2B

Sources

Lemonade Q3 2025 Shareholder Letter (metrics, guidance, operating commentary). ^[16]
Reinsurance News wrap of the results (net loss, IFP, revenue detail). ^[17]
Investing.com coverage/transcript excerpts (EPS beat, loss‑ratio comments). ^[18]
Investors Business Daily on stock reaction, EPS, buy‑point context. ^[19]
Yahoo Finance live/recap items noting the surge and 52‑week highs/YTD move. ^[20]

Note: This article is for information only and is not investment advice. Always do your own research or consult a licensed advisor before making trading decisions.

References

1. www.lemonade.com, 2. www.lemonade.com, 3. www.lemonade.com, 4. www.lemonade.com, 5. www.lemonade.com, 6. www.lemonade.com, 7. www.lemonade.com, 8. www.lemonade.com, 9. www.lemonade.com, 10. www.investing.com, 11. finance.yahoo.com, 12. www.lemonade.com, 13. www.lemonade.com, 14. www.lemonade.com, 15. www.lemonade.com, 16. www.lemonade.com, 17. www.reinsurancene.ws, 18. www.investing.com, 19. www.investors.com, 20. finance.yahoo.com

Tags:

Marcin Frąckiewicz Latest posts

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

View all

KGC vs FNV: Which Is the Better Value Stock Right Now?
November 5, 2025, 5:00 PM EST. Among Mining - Gold stocks, Kinross Gold (KGC) and Franco-Nevada (FNV) both carry a Zacks Rank of #2 (Buy). The analysis highlights that while both stocks show improving earnings outlooks, KGC delivers stronger Value signals: forward P/E of 16.06 versus 37.56 for FNV, a PEG of 0.54 versus 20.41, and a P/B of 1.75 versus 4.01. As a result, KGC earns a Value grade of A, while FNV scores F. The takeaway: on traditional value metrics, KGC appears the more compelling option right now, even as both firms show solid earnings momentum under the Zacks framework.
UBSI Bulls Cross Above 200-Day Moving Average
November 5, 2025, 4:56 PM EST. United Bankshares Inc. (UBSI) rose after its shares crossed above the 200-day moving average of $36.36, hitting as high as $36.73 and trading about 2.2% higher on the session. The breakout above the long-term trend line suggests a bullish signal as price tests critical resistance near the 200-day mark. UBSI was last near $36.47, well within its 52-week range of $31.74-$42.50. If the move sustains with solid volume, traders may add to upside momentum with the 200-day line acting as potential support. This cross forms part of a broader pattern of dividend stocks crossing above key moving averages.
Omron Corp (OMRNY) Dips Below 200-Day Moving Average
November 5, 2025, 4:54 PM EST. On Wednesday, Omron Corp (OMRNY) slid below its 200-day moving average of $28.16, trading as low as $27.85 and down about 2.7% for the session. The chart shows Omron's one-year performance relative to its 200-day average. The stock's 52-week range runs from $24.164 to $39.65, with the latest trade near $27.87. A break below the moving average can signal waning near-term momentum, though traders should weigh volume, catalysts, and broader market context. If the pattern persists, watch for support near the 200-day line or a potential rebound, alongside any company news and macro factors. The note also teases which other stocks recently crossed below their 200-day moving average.
MasterBrand (MBC) Steps into Oversold Territory as RSI Hits 29.8
November 5, 2025, 4:48 PM EST. MasterBrand Inc (MBC) has slipped into oversold territory after the stock's RSI tumbled to 29.8, with intraday prints as low as $8.255. By comparison, the SPY's RSI sits around 39.0, highlighting a broader market backdrop. The setup could tempt bullish traders to view the read as a potential entry point as selling pressure abates. On the year, MBC traded near a 52-week low of $7.17 and a high of $10.21, with the latest trade around $8.24. The RSI signal adds a behavioral read to Buffett's adage: be wary when others are greedy, and seek opportunity when fear dominates across stocks.
RSI Alert: Kyndryl Holdings (KD) Hits Oversold Territory at 25.2
November 5, 2025, 4:46 PM EST. KD slipped into oversold territory as its RSI fell to 25.2, signaling potential exhaustion of recent selling. KD traded down to $28.77, while the SPY sits around a 46.0 RSI, underscoring the relative weakness. A trader could view the move as a possible setup for a reversal entry if momentum steadies. KD's 52-week range runs from a low of $19.24 to a high of $43.61, with the latest trade near $29.79. Investors should weigh risk, consider volume cues, and monitor for a bounce or further weakness before committing new capital. The piece also points readers to nine other oversold stocks.